Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer
ConclusionsANXA10 expression was upregulated in PTC, and it was an independent prognostic biomarker of PTC, suggesting that ANXA10 may be a promising target for individual treatment of ANXA10.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | General Medicine | Ireland Health | Science | Study | Thyroid | Thyroid Cancer